Colorectal Cancer
Conditions
Interventions
None listed
Sponsors
Kyorin University School of Medicine The Third Department of Internal Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A) Colorectal cancer patients (regardless of cancer stages). In Kyorin university, colorectal adenoma is also included. B) Age 25-90 C) People who agreed to the informed consent to participate in the study
Exclusion criteria
Exclusion criteria: A) Subjects who have taken any amino acid-formulations, supplements, and beverage within 8 hours before the blood collection. B) Subjects who have taken meals and beverage other than water within 8 hours before the blood collection. C) Subjects who are under medical treatment for any cancer including colorectal cancer (surgery, drug treatment, chemotherapy, radiation therapy) or who underwent surgery to remove cancer within 1 year. D) Subjects who have double cancer. E) Subjects who are pregnant or breast-feeding. F) Patients of inborn error of metabolism. G) Dialysis patients H) Subjects who are judged as ineligible by the medical doctors who are responsible for this trial as investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma concentrations of metabolites that have amino moieties and other metabolites | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose, HbA1c Tumor markers (CEA, CA19-9 etc.) Stage of cancer Site of cancer Result of pathological examination Tissue type of cancer Tumor size Clinical parameters obtained in health chek-up | — |
Countries
Japan
Contacts
Public ContactHidehiro Nakamura
Ajinomoto Co., Inc. Research Institute for Bioscience Products & Fine Chemicals
Outcome results
None listed